Valued at USD 14.21 billion in 2024, the oncology clinical trials market is projected to reach USD 14.93 billion in 2025 and USD 23.50 billion by 2034, growing at a CAGR of 5.17% during the forecast period 2025–2034. Clinical trials assess new treatments, including targeted therapies, immunotherapies, and combination therapies, for safety and efficacy before approval. Growth is driven by...